Guangdong Marubi Biotechnology Co (603983) — Cash Flow Quality Index
Guangdong Marubi Biotechnology Co (603983) has a Cash Flow Quality Index of 0.74x as of September 2025. Operating cash flow of CN¥43.25 Million is below net income of CN¥58.15 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Guangdong Marubi Biotechnology Co (603983) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangdong Marubi Biotechnology Co Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Guangdong Marubi Biotechnology Co across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 603983 cash flow metrics.
Annual Cash Flow Quality Index for Guangdong Marubi Biotechnology Co (2011–2025)
Year-by-year earnings quality comparison for Guangdong Marubi Biotechnology Co.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.11x | CN¥273.88 Million | CN¥247.24 Million | ▲ +26.2% |
| 2024 | 0.88x | CN¥300.53 Million | CN¥342.36 Million | ▼ -32.6% |
| 2023 | 1.30x | CN¥338.02 Million | CN¥259.42 Million | ▲ +350.4% |
| 2022 | 0.29x | CN¥48.44 Million | CN¥167.43 Million | ▲ +1032.7% |
| 2021 | -0.03x | CN¥-7.48 Million | CN¥241.19 Million | ▼ -104.0% |
| 2020 | 0.78x | CN¥362.35 Million | CN¥463.40 Million | ▼ -13.9% |
| 2019 | 0.91x | CN¥465.53 Million | CN¥512.82 Million | ▼ -27.6% |
| 2018 | 1.25x | CN¥516.69 Million | CN¥412.04 Million | ▲ +9.8% |
| 2017 | 1.14x | CN¥356.20 Million | CN¥311.92 Million | ▲ +24.3% |
| 2016 | 0.92x | CN¥213.33 Million | CN¥232.19 Million | ▼ -6.0% |
| 2015 | 0.98x | CN¥275.11 Million | CN¥281.43 Million | ▼ -29.5% |
| 2014 | 1.39x | CN¥376.24 Million | CN¥271.37 Million | ▼ -6.9% |
| 2013 | 1.49x | CN¥325.67 Million | CN¥218.61 Million | ▲ +22.4% |
| 2012 | 1.22x | CN¥227.49 Million | CN¥186.86 Million | ▼ -24.4% |
| 2011 | 1.61x | CN¥269.39 Million | CN¥167.26 Million | — |